Twist Bioscience narrows loss, raises full-year outlook on NGS strength
Twist Bioscience (NASDAQ:TWST) reported first-quarter fiscal 2026 results Monday that beat revenue expectations and showed significant margin improvement, as the company stays on track to reach its profitability goals by the end of the year.





-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)




-640x400.jpg&w=1200&q=75)








